Cong Claire Xu, SVP, Clinical Development at NovaBridge Biosciences (NBP), sold 4,485 shares at $0.89 ($4K) on 2026-07-06, disclosed to the SEC on 2026-07-07.
Open-market sale of $4k NBP by SVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.